Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-1.23%
SPX
-1.60%
IXIC
-2.24%
FTSE
-0.70%
N225
-0.66%
AXJO
-0.92%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Recently from Cashu

publisher logo
Cashu

Celcuity's VIKTORIA-1 Trial Promises New Hope for Breast Cancer Treatment

3 days ago
publisher logo
Cashu

Celcuity's VIKTORIA-1 Trial Offers Hope for Breast Cancer Treatment Breakthrough

4 days ago
publisher logo
Cashu

Celcuity's VIKTORIA-1 Trial Results Boost Breast Cancer Treatment Innovation

6 days ago

Key Stats

Market Cap
1.51B
Dividend Yield
0.00%
P/E Ratio
-11.88
EPS
-2.83
Revenue
-
Avg. Volume
8.61M

About

What does CELC do?
Celcuity, based in Minneapolis, employs 55 staff and went public on September 20, 2017. Its lead candidate, gedatolisib, targets specific cancer pathways and is in trials for advanced breast and prostate cancer.
Sector
💻 Health Care
IPO
CEO
Employees
87 employees
Headquarters
Minnesota, USA
Website
http://www.celcuity.com
Stocks
Health Care
celc
Celcuity
NASDAQ: CELC
+0.72 (+1.83%)
39.88
USD
At close at Aug 01, 20:42 UTC
Summary
News
Signals
Benchmarks
Financials